FDA notifications.  Tentative approval for generic nevirapine tablets.
D017277:Drug Approval / Q000331:legislation & jurisprudence*; D016568:Drugs, Generic / Q000008:administration & dosage / Q000627:therapeutic use*; D006801:Humans; D019829:Nevirapine / Q000008:administration & dosage / Q000627:therapeutic use*; D018894:Reverse Transcriptase Inhibitors / Q000008:administration & dosage / Q000627:therapeutic use*; D013607:Tablets; D014481:United States; D014486:United States Food and Drug Administration
D016568:Drugs, Generic; D018894:Reverse Transcriptase Inhibitors; D013607:Tablets; D019829:Nevirapine